Downregulated MTAP expression in myxofibrosarcoma

A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance

Chien Feng Li, Fu Min Fang, Hsing Jien Kung, Li Tzong Chen, Jun Wen Wang, Jen Wei Tsai, Shih Chen Yu, Yu Hui Wang, Shau Hsuan Li, Hsuan Ying Huang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Myxofibrosarcomas are genetically complex and involve recurrently deleted chromosome 9p, for which we characterized the pathogenically relevant target(s) using genomic profiling. In 12 of the 15 samples, we detected complete or partial losses of 9p. The only aggressiveness-associated, differentially lost region was 9p21.3, spanning the potential inactivated methylthioadenosine phosphorylase (MTAP) that exhibited homozygous (4/15) or hemizygous (3/15) deletions. In independent samples, MTAP gene status was assessed using quantitative- and methylation-specific PCR assays, and immunoexpression was evaluated. We applied MTAP reexpression or knockdown to elucidate the functional roles of MTAP and the therapeutic potential of L-alanosine in MTAP-preserved and MTAP-deficient myxofibrosarcoma cell lines and xenografts. MTAP protein deficiency (37%) was associated with MTAP gene inactivation (P < 0.001) by homozygous deletion or promoter methylation, and independently portended unfavorable metastasis-free survival (P = 0.0318) and disease-specific survival (P = 0.014). Among the MTAPdeficient cases, the homozygous deletion of MTAP predicted adverse outcome. In MTAP-deficient cells, MTAP reexpression inhibited cell migration and invasionproliferation, and anchorage-independent colony formation and downregulated cyclin D1. This approach also attenuated the tube-forming abilities of human umbilical venous endothelial cells, attributable to the transcriptional repression of MMP-9, and abrogated the susceptibility to L-alanosine. The inhibiting effects of MTAP expression on tumor growth, angiogenesis, and the induction of apoptosis by L-alanosine were validated using MTAP-reexpressing xenografts and reverted using RNA interference in MTAP-preserved cells. In conclusion, homozygous deletion primarily accounts for the adverse prognostic impact of MTAP deficiency and confers the biological aggressiveness and susceptibility to L-alanosine in myxofibrosarcomas.

Original languageEnglish
Pages (from-to)11428-11441
Number of pages14
JournalOncotarget
Volume5
Issue number22
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Down-Regulation
alanosine
Neoplasms
Therapeutics
5'-methylthioadenosine phosphorylase
Heterografts
Methylation
Umbilicus
Protein Deficiency
Survival
Cyclin D1
Gene Silencing
RNA Interference
Matrix Metalloproteinases
Cell Movement
Endothelial Cells
Chromosomes
Apoptosis
Neoplasm Metastasis
Cell Line

Keywords

  • Homozygous deletion
  • Methylation
  • MTAP
  • Myxofibrosarcoma

ASJC Scopus subject areas

  • Oncology

Cite this

Downregulated MTAP expression in myxofibrosarcoma : A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance. / Li, Chien Feng; Fang, Fu Min; Kung, Hsing Jien; Chen, Li Tzong; Wang, Jun Wen; Tsai, Jen Wei; Yu, Shih Chen; Wang, Yu Hui; Li, Shau Hsuan; Huang, Hsuan Ying.

In: Oncotarget, Vol. 5, No. 22, 01.01.2014, p. 11428-11441.

Research output: Contribution to journalArticle

Li, Chien Feng ; Fang, Fu Min ; Kung, Hsing Jien ; Chen, Li Tzong ; Wang, Jun Wen ; Tsai, Jen Wei ; Yu, Shih Chen ; Wang, Yu Hui ; Li, Shau Hsuan ; Huang, Hsuan Ying. / Downregulated MTAP expression in myxofibrosarcoma : A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance. In: Oncotarget. 2014 ; Vol. 5, No. 22. pp. 11428-11441.
@article{886c64d4ddcf45e981f5235eebc98fd2,
title = "Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance",
abstract = "Myxofibrosarcomas are genetically complex and involve recurrently deleted chromosome 9p, for which we characterized the pathogenically relevant target(s) using genomic profiling. In 12 of the 15 samples, we detected complete or partial losses of 9p. The only aggressiveness-associated, differentially lost region was 9p21.3, spanning the potential inactivated methylthioadenosine phosphorylase (MTAP) that exhibited homozygous (4/15) or hemizygous (3/15) deletions. In independent samples, MTAP gene status was assessed using quantitative- and methylation-specific PCR assays, and immunoexpression was evaluated. We applied MTAP reexpression or knockdown to elucidate the functional roles of MTAP and the therapeutic potential of L-alanosine in MTAP-preserved and MTAP-deficient myxofibrosarcoma cell lines and xenografts. MTAP protein deficiency (37{\%}) was associated with MTAP gene inactivation (P < 0.001) by homozygous deletion or promoter methylation, and independently portended unfavorable metastasis-free survival (P = 0.0318) and disease-specific survival (P = 0.014). Among the MTAPdeficient cases, the homozygous deletion of MTAP predicted adverse outcome. In MTAP-deficient cells, MTAP reexpression inhibited cell migration and invasionproliferation, and anchorage-independent colony formation and downregulated cyclin D1. This approach also attenuated the tube-forming abilities of human umbilical venous endothelial cells, attributable to the transcriptional repression of MMP-9, and abrogated the susceptibility to L-alanosine. The inhibiting effects of MTAP expression on tumor growth, angiogenesis, and the induction of apoptosis by L-alanosine were validated using MTAP-reexpressing xenografts and reverted using RNA interference in MTAP-preserved cells. In conclusion, homozygous deletion primarily accounts for the adverse prognostic impact of MTAP deficiency and confers the biological aggressiveness and susceptibility to L-alanosine in myxofibrosarcomas.",
keywords = "Homozygous deletion, Methylation, MTAP, Myxofibrosarcoma",
author = "Li, {Chien Feng} and Fang, {Fu Min} and Kung, {Hsing Jien} and Chen, {Li Tzong} and Wang, {Jun Wen} and Tsai, {Jen Wei} and Yu, {Shih Chen} and Wang, {Yu Hui} and Li, {Shau Hsuan} and Huang, {Hsuan Ying}",
year = "2014",
month = "1",
day = "1",
doi = "10.18632/oncotarget.2552",
language = "English",
volume = "5",
pages = "11428--11441",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "22",

}

TY - JOUR

T1 - Downregulated MTAP expression in myxofibrosarcoma

T2 - A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance

AU - Li, Chien Feng

AU - Fang, Fu Min

AU - Kung, Hsing Jien

AU - Chen, Li Tzong

AU - Wang, Jun Wen

AU - Tsai, Jen Wei

AU - Yu, Shih Chen

AU - Wang, Yu Hui

AU - Li, Shau Hsuan

AU - Huang, Hsuan Ying

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Myxofibrosarcomas are genetically complex and involve recurrently deleted chromosome 9p, for which we characterized the pathogenically relevant target(s) using genomic profiling. In 12 of the 15 samples, we detected complete or partial losses of 9p. The only aggressiveness-associated, differentially lost region was 9p21.3, spanning the potential inactivated methylthioadenosine phosphorylase (MTAP) that exhibited homozygous (4/15) or hemizygous (3/15) deletions. In independent samples, MTAP gene status was assessed using quantitative- and methylation-specific PCR assays, and immunoexpression was evaluated. We applied MTAP reexpression or knockdown to elucidate the functional roles of MTAP and the therapeutic potential of L-alanosine in MTAP-preserved and MTAP-deficient myxofibrosarcoma cell lines and xenografts. MTAP protein deficiency (37%) was associated with MTAP gene inactivation (P < 0.001) by homozygous deletion or promoter methylation, and independently portended unfavorable metastasis-free survival (P = 0.0318) and disease-specific survival (P = 0.014). Among the MTAPdeficient cases, the homozygous deletion of MTAP predicted adverse outcome. In MTAP-deficient cells, MTAP reexpression inhibited cell migration and invasionproliferation, and anchorage-independent colony formation and downregulated cyclin D1. This approach also attenuated the tube-forming abilities of human umbilical venous endothelial cells, attributable to the transcriptional repression of MMP-9, and abrogated the susceptibility to L-alanosine. The inhibiting effects of MTAP expression on tumor growth, angiogenesis, and the induction of apoptosis by L-alanosine were validated using MTAP-reexpressing xenografts and reverted using RNA interference in MTAP-preserved cells. In conclusion, homozygous deletion primarily accounts for the adverse prognostic impact of MTAP deficiency and confers the biological aggressiveness and susceptibility to L-alanosine in myxofibrosarcomas.

AB - Myxofibrosarcomas are genetically complex and involve recurrently deleted chromosome 9p, for which we characterized the pathogenically relevant target(s) using genomic profiling. In 12 of the 15 samples, we detected complete or partial losses of 9p. The only aggressiveness-associated, differentially lost region was 9p21.3, spanning the potential inactivated methylthioadenosine phosphorylase (MTAP) that exhibited homozygous (4/15) or hemizygous (3/15) deletions. In independent samples, MTAP gene status was assessed using quantitative- and methylation-specific PCR assays, and immunoexpression was evaluated. We applied MTAP reexpression or knockdown to elucidate the functional roles of MTAP and the therapeutic potential of L-alanosine in MTAP-preserved and MTAP-deficient myxofibrosarcoma cell lines and xenografts. MTAP protein deficiency (37%) was associated with MTAP gene inactivation (P < 0.001) by homozygous deletion or promoter methylation, and independently portended unfavorable metastasis-free survival (P = 0.0318) and disease-specific survival (P = 0.014). Among the MTAPdeficient cases, the homozygous deletion of MTAP predicted adverse outcome. In MTAP-deficient cells, MTAP reexpression inhibited cell migration and invasionproliferation, and anchorage-independent colony formation and downregulated cyclin D1. This approach also attenuated the tube-forming abilities of human umbilical venous endothelial cells, attributable to the transcriptional repression of MMP-9, and abrogated the susceptibility to L-alanosine. The inhibiting effects of MTAP expression on tumor growth, angiogenesis, and the induction of apoptosis by L-alanosine were validated using MTAP-reexpressing xenografts and reverted using RNA interference in MTAP-preserved cells. In conclusion, homozygous deletion primarily accounts for the adverse prognostic impact of MTAP deficiency and confers the biological aggressiveness and susceptibility to L-alanosine in myxofibrosarcomas.

KW - Homozygous deletion

KW - Methylation

KW - MTAP

KW - Myxofibrosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84917690856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84917690856&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.2552

DO - 10.18632/oncotarget.2552

M3 - Article

VL - 5

SP - 11428

EP - 11441

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 22

ER -